Top Section/Ad
Top Section/Ad
Most recent
A handful of large new listings have emerged from South Africa, Kenya and Angola and more are set to follow
Submarine mast maker's IPO raised €132.8m
Vincorion is expected to continue defence IPOs later this week
More articles/Ad
More articles/Ad
More articles
-
Hong Kong has had its first taste of a pre-revenue biotechnology stock with the listing by Ascletis Pharma. Unfortunately, the company got caught up in a wave of volatility and the shares have not fared well. It was not a good start for biotech but the sector should not be judged by this one deal, as it was just the first from a bulging IPO pipeline. -
Haidilao International Holding plans to launch its $1bn IPO in Hong Kong by the end of the month, according to bankers working on the deal.
-
Shanghai Junshi Biosciences is eyeing a $500m IPO in Hong Kong, having filed a draft prospectus with the city’s stock exchange.
-
China Everbright Water has mooted a dual-listing of its shares on the Main Board of the Hong Kong Stock Exchange, in a deal bankers say could raise $200m.
-
Swiss Re is considering a sale of its closed book life business ReAssure, possibly in 2019, in order to raise capital to buy more polices, a deal which could be worth over £875m.
-
Shangde Qizhi Education Group has set the ball rolling for a Hong Kong IPO, having filed a draft prospectus with the city’s bourse on Thursday.
